Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership

S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership

PEDEVCO (AMEX:PED)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more PEDEVCO Charts.

PEDEVCO (AMEX:PED)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more PEDEVCO Charts.

PEDEVCO Corp New News

Form 8-K - Current report
Tuesday 4 February 2025 (1 day ago) • Edgar (US Regulatory)

Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership
Monday 27 January 2025 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 27 January 2025 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 27 January 2025 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 27 January 2025 (1 week ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Thursday 2 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 31 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 20 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Friday 20 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 11 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 14 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 14 November 2024 (3 months ago) • Edgar (US Regulatory)

More PEDEVCO Corp New News Articles

Adia Nutrition (PK)

Decentral Life (PK)

MineralRite (PK)

TransCode Therapeutics

RespireRx Pharmaceuticals (CE)

Virexit Technologies (PK)

Liquidmetal Technologies (QB)

Elite Pharmaceuticals (QB)

Enanta Pharmaceuticals

Rennova Health (CE)

Super Micro Computer

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions